EDG-2 Antagonist Form 1 Crystallization Using Citric Acid Slurry
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Reliably producing a single crystalline form of 2-(4-methoxy-3-(3-methylphenethoxy)benzamido)-2,3-dihydro-1H-indene-2-carboxylic acid (Compound I) is challenging due to its propensity to crystallize as mixtures of polymorphs under tight temperature and pH conditions, making large-scale manufacturing difficult.
Innovation Solution
A method for producing crystalline Form 1 of Compound I involves adding a compound of Formula 2 to a slurry of citric acid in a suitable solvent, followed by filtration, without the need for seeds of Form 1, using solvents like tetrahydrofuran, methanol, or a mixture of methanol and water, and controlling temperature and pH conditions to achieve consistent crystallization.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If tight temperature and pH conditions are used to prevent self-crystallization into polymorph mixtures, then crystalline form purity is improved, but manufacturing reliability deteriorates due to the narrow process window
Solution Approach 1:
The patent introduces citric acid as an intermediary substance that mediates the crystallization process. The citric acid slurry acts as a controlled environment that prevents direct self-crystallization of Compound I, thereby eliminating the need for tight temperature and pH control while ensuring reliable production of pure crystalline Form 1
Solution Approach 2:
The patent changes the physical state parameter of the reaction medium by using a citric acid slurry instead of a clear solution. This parameter change transforms the crystallization environment from one requiring precise temperature and pH control to one that inherently stabilizes single polymorph formation through the slurry matrix
2Manufacturing precision
If seeds of Form 1 are used to ensure single polymorph crystallization, then crystalline form purity is improved, but process complexity increases
Solution Approach 1:
The citric acid slurry serves as an intermediary that replaces the need for Form 1 seeds. The slurry provides a controlled crystallization environment that inherently directs formation of pure Form 1 without requiring external seed crystals, thereby simplifying the overall process
Solution Approach 2:
The patent replaces the use of valuable Form 1 seed crystals with a inexpensive citric acid slurry that can be easily prepared and discarded after use. This substitution eliminates the need for seed crystal preparation, storage, and handling while achieving the same crystallization control
3Productivity
If Compound I is allowed to crystallize from supersaturated solution, then production efficiency is improved, but polymorph mixture formation increases
Solution Approach 1:
The citric acid slurry acts as a mediator that allows rapid crystallization from supersaturated solution without forming polymorph mixtures. The slurry matrix provides controlled nucleation sites that direct single polymorph formation even under high supersaturation conditions, enabling both high productivity and high purity
Solution Approach 2:
The patent performs preliminary preparation of citric acid slurry before adding Compound I. This preliminary action creates a pre-conditioned environment that is ready to control crystallization immediately upon Compound I addition, allowing rapid crystallization while maintaining pure Form 1 formation from the start
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method allows for the reliable production of high-purity Crystalline Form 1 of Compound I, characterized by specific X-ray powder diffraction peaks, enhancing its suitability for pharmaceutical applications.
Implementation Method 1
A process for the preparation of crystalline Form 1 of 2-(4-methoxy-3-(3-methylphenethoxy)benzamido)-2,3-dihydro-1H-indene-2-carboxylic acid (Compound I)... adding a mixture comprising a compound of Formula 2... in a suitable solvent onto a slurry of citric acid; and isolating the Crystalline Form 1 of Compound I by filtration
Data Source
AI summary
Described herein are methods of making crystalline Form 1 of 2-(4-methoxy-3-(3-methylphenethoxy)benzamido)-2,3-dihydro-1H-indene-2-carboxylic acid.